Sophia Genetics (SOPH) has announced a new collaboration with Jessa Ziekenhuis in Hasselt, Belgium. The institutions will partner to bring genomic testing and oncology research to cancer patients across Belgium. Jessa Ziekenhuis, one of Belgium’s largest healthcare institutions, serves a population of over 530,000 and processes more than 3,000 oncology DNA and RNA samples annually. Through this collaboration, the hospital will adopt Sophia DDM across its pathology operations. The hospital will implement six Sophia Genetics applications tailored to its testing needs in solid tumors, hematologic malignancies, and liquid biopsy analysis.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOPH: